Return of Actionable Variants Empirical Study
NCT03640234 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 418
Last updated 2022-09-27
Summary
This is a genomic implementation project with ancillary studies to understand the impact on patients' health and well-being of returning genomic results to them and depositing those results in the medical record.
Conditions
- Familial Hypercholesterolemia
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
National Human Genome Research Institute (NHGRI)
collaborator NIH - lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-02-25
- Primary Completion
- 2022-09-01
- Completion
- 2022-09-01
More Related Trials
-
Pharmacogenomics Registry to Assess Clinical Utility
NCT02374840 ·Status: UNKNOWN
-
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
NCT02081872 ·Status: UNKNOWN
-
Clinical Integration of Genetic Risk Assessment in Family Medicine
NCT00339794 ·Status: COMPLETED
-
Refining Information Technology Support for Genetics in Medicine
NCT01225978 ·Status: UNKNOWN
-
Pilot of Preemptive Pharmacogenetics in Medically Underserved Patients
NCT04630093 ·Status: COMPLETED ·Phase: NA
-
Use of Virtual Reality to Communicate Concepts of Genomics to the General Public
NCT00316056 ·Status: COMPLETED
-
Early Onset Alzheimer's Disease Genomic Study
NCT03645993 ·Status: COMPLETED
-
Reproducibility of the Array-Based Comparative Genomic Hybridization (aCGH) System Using Whole Blood Samples
NCT00214448 ·Status: UNKNOWN
-
Utility of Pharmacogenomic Testing in Patients With Gastrointestinal Disorders
NCT05572593 ·Status: COMPLETED ·Phase: NA
-
Prenatal Microarray Follow-Up Study
NCT02160938 ·Status: COMPLETED
-
Genetic Predictors of Raltegravir Penetration Into Cerebrospinal Fluid
NCT00729924 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Developing an Interdisciplinary Pharmacogenomic Treatment Approach to Reduce Medication Burden and Improve Outcomes
NCT01274065 ·Status: COMPLETED
-
Identification of Genomic Loci Determining Susceptibility to the Development of High Myopia
NCT02583620 ·Status: COMPLETED ·Phase: NA
-
Genetic Variation in Platelet Aggregation
NCT01576536 ·Status: COMPLETED
-
Preemptive Pharmacogenomics Testing Among Geriatric Patients
NCT05091879 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Decoding Developmental Disorders in Humams
NCT06260319 ·Status: COMPLETED
-
A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
NCT06092346 ·Status: RECRUITING
-
Rare and Undiagnosed Disease Research Biorepository
NCT04703179 ·Status: ENROLLING_BY_INVITATION
-
Genetics of COVID-19 Susceptibility and Manifestations
NCT04371432 ·Status: COMPLETED
-
Overcoming Barriers to Accessing Genetic Medicine
NCT05064241 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Genetics of Uveitis
NCT02357238 ·Status: RECRUITING
-
Genetic Inclusion by Virtual Evaluation
NCT05318222 ·Status: RECRUITING ·Phase: NA
-
Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II
NCT00089882 ·Status: COMPLETED
-
The Informed Genetics Annotated Patient Registry
NCT04419896 ·Status: ENROLLING_BY_INVITATION
-
Family Studies of Eye Traits
NCT00342342 ·Status: COMPLETED